- eXoZymes press release (EXOZ): Q2
- Operating expenses for the second quarter of 2026 were $2.95 million, compared with $2.55 million for the same period in 2025.
- Net loss was $2.88 million for the quarter and $5.25 million for the six months ended June 30, 2026.
- The Company ended the quarter with $5.65 million in cash and cash equivalents, which the Company expects will support operations through the end of 2026.
